Commercialization of University Technology: A Faculty Perspective
The CU Technology Transfer Office and the Colorado Alliance for Bioengineering present the BioBusiness Seminar Series: "Commercialization of University Technology: A Faculty Perspective" with Michael Bristow, M.D., Ph.D., Chief, Division of Cardiology, UCHSC, Co-founder, Myogen, Inc.
Thursday, September 5th
7:00-8:00am: Breakfast and Networking
Dr. Bristow will discuss his experience commercializing University of Colorado intellectual property by founding Myogen. Myogen is a venture backed biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for the treatment of heart failure and related cardiovascular conditions. Dr. Bristow will discuss the commercialization process; from idea inception, to working with the University, through licensing and commercialization. This discussion will take place in a seminar setting, and focus on having faculty questions addressed by a peer who has been through the process. Please join us for what promises to be an interactive and informative seminar.